COVID-19 Vaccines

COVID-19 Vaccine Participant Develops Neurological Symptoms, AstraZeneca Pauses Trial

By Jeremy Loffredo © September 11, 2020 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts. On

COVID-19 Vaccine Participant Develops Neurological Symptoms, AstraZeneca Pauses Trial Read More »

ICAN Calls for COVID-19 vaccine safety trials to last as long as the clinical trials

Few people are aware that the safety arms of vaccine clinical trials typically last a few days or weeks, rarely for a few months, and that long term safety studies are never done before the products are brought to market. That makes all who accept a vaccine subjects of Phase 4 “aftermarket” clinical trials.  Once

ICAN Calls for COVID-19 vaccine safety trials to last as long as the clinical trials Read More »